Autopsy report · NCT05337774

Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury

“study funding period ended March 2022”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months after it had already started.
• Ran for about 11 months before it stopped.
• 18 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Life Molecular Imaging SA.

Sponsor type

Industry

Conditions

Mild Traumatic Brain Injury

Interventions

[18F]PI-2620

Participants

18

Sites

1

Countries

United States

Trials that died the same way

• Field Administration of Stroke Therapy-Blood Pressure Lowering
  “The funding period for the study has ended.” (84% match in meaning)
• Longitudinal Geriatric Assessment to Optimize Outcomes of Older Patients With Muscle-Invasive Bladder Cancer After Radical Cystectomy
  “Study funds ended on 7/31/2023” (84% match in meaning)
• Abuse Potential of Buprenorphine/Naloxone
  “Funding ended for the study” (82% match in meaning)
• Managing Chronic Tendon Pain by Metformin
  “The study funding has ended.” (81% match in meaning)
• Role of FCI in the Detection of Proctosigmoiditis Caused by IBD
  “Funding period ended” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.